Sofia Cortes (S.Cortes) is presently Assistant Researcher at the Medical Parasitology Unit of IHMT NOVA, and an active member of the Vector-Borne Diseases (VBD) group of the Global Health & Tropical Medicine (GHTM) R&D Center.
She has a degree in Biology by the University of Aveiro. In 2009 at NOVA, she completed her PhD in Biomedical Sciences (Specialization Parasitology) under the supervision of Prof. Lenea Campino. From 2009-2014 she had an FCT postdoctoral grant at IHMT (research in phenotypic studies associated with virulence of Leishmania sp. and hybrids). In 2014, she was awarded with a two-year Marie Skłodowska-Curie grant at the Technical University of Applied Sciences Wildau (TH Wildau), Germany (research related to biomarkers in Leishmania sp.). In 2017 she got a position of Assistant researcher at IHMT under an FCT Investigator starting grant (studies to find active compounds synthetic compounds against Leishmania sp.). To date S. Cortes participated in 12 competitive research projects, 5 of them international (EU/FP6, EU/FP7, BMBF), one as principal Investigator and 2 international networks. S.Cortes is author or co-author of 1 book chapter, 47 publications of which 36 in WOS journals, 16 as first author, with a total of 904 citations and an h-Index of 16.
Since 2009 S. Cortes lectured in undergraduate and post-graduate courses (MsC & PhD) in national universities (NOVA, Algarve University- UAlg, Católica, Porto University) and international (Agostinho Neto University- Angola, TH Wildau- Germany, and UniCV- Cape Verde). She was responsible for supervision of undergraduate and graduate students, and has been developing a worldwide network within Institutions of different countries (Belgium, Czech Republic, France, Germany, Greece, Italy, Spain, Nederland, UK, Argentine, Brazil, Paraguay, Angola, Armenia, Malaysia, Morocco, South Africa, Tunisia, Uzbekistan).
Expertise fields: Veterinary and Health Sciences with emphasis on Parasitology, Human and canine leishmaniasis.
Research topics: Drug discovery; Leishmania; Drug susceptibility studies with synthetic and natural compounds; in vivo studies; host-parasite interactions; molecular diagnostics; leishmaniasis epidemiology; Trypanosomatids; proteomics; TEM; flow cytometry.
- Cortes et al. 2019. Elucidating in vitro and in vivo phenotypic behaviour of L. infantum/L. major natural hybrids. Parasitol, 146: 580–7.
- Hornemann et al. 2017. A pilot study on fingerprinting Leishmania species from the Old-World using Fourier transform infrared spectroscopy Anal Bioanal Chem, 409: 6907-23.
- Cortes et al. 2015. In vitro susceptibility of Leishmania infantum to Artemisinin derivatives and selected trioxolanes. Antimicrob Agents Chemother. 59,5032–5.
- Cortes et al. 2014. Genetic diversity evaluation on Portuguese Leishmania infantum strains by Multilocus Microsatellite Typing. Infect Genet Evol 26: 20-31.
- Cortes et. 2012. Risk factors for canine leishmaniasis in an endemic Mediterranean region. Vet Parasitol 189: 189-196.